Clinical Trials Browser

Phase 2 × trimebutine 3-thiocarbamoylbenzenesulfonate × Clear all

NCT01926444 2019-05-08

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Phase 2 Completed

308 enrolled 14 charts

Gastrointestinal

Agnosia, Colonic Diseases, Neoplasms, Pain, Colorectal Neoplasms